Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078143 · ClinicalTrials.gov registry record · Phase 3
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
A Phase 3 study of Substance-Related Disorders, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 6
- Study locations
NCT00078143 is a Phase 3 study of Substance-Related Disorders that has completed, run by University of Cincinnati. The registered enrollment target is 200 participants, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (87% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT00078143, a Phase 3 study of Substance-Related Disorders, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.
Conditions Studied
Interventions
- BEHAVIORAL Behavior Therapy
Study Locations (6)
New Mexico
- Milagro Clinic - Albuquerque
- Milagro - Albuquerque
Indiana
- Midtown Community Mental Health Center - Indianapolis
Kentucky
- Jefferson Alcohol & Drug Abuse Center - Louisville
Michigan
- Eleonore Hutzel Recovery Center - Detroit
North Carolina
- Coastal Horizons Center, Inc. - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2003-10 |
| Est. Completion | 2006-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00078143
The ClinicalTrials.gov registry entry for NCT00078143 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (87% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Behavior Therapy is the first listed.
NCT00078143 reports 6 study locations spanning 5 distinct geographic areas - top geographies include New Mexico, Indiana, Kentucky.
Frequently Asked Questions
What is clinical trial NCT00078143 about?
NCT00078143 is a clinical study titled "Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1". The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.
What is the current status of trial NCT00078143?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2003-10. Estimated completion is 2006-04.
What conditions does trial NCT00078143 study?
This clinical trial studies the following conditions: Substance-Related Disorders.
What interventions are being tested in trial NCT00078143?
The interventions under investigation include: Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00078143?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078143 being conducted?
This trial has 6 study locations across Indiana, Kentucky, Michigan, New Mexico, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
COMPLETED · Phase 3
-
Women's Treatment for Trauma and Substance Use Disorders - 1
COMPLETED · Phase 3
-
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
COMPLETED · Phase 3
-
Job-Seekers Training for Patients With Drug Dependence - 1
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.